pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 11·1 min read
save

Study finds socioeconomic status drives brain development differences in 9- and 10-year-olds

Jun 11, 2026·read at STAT ↗Neutral

Researchers at Washington University School of Medicine examined brain MRI scans from almost 12,000 children who were nine or ten years old.

The analysis showed that a child's socioeconomic background was the strongest environmental predictor of both brain structure and functional measures, outweighing other factors examined.

The authors suggest that chronic stress and irregular sleep patterns common in lower-income neighborhoods may underlie the observed differences, highlighting the role of social conditions in early neural development.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Study highlights influence of socioeconomic status on children’s brain development”

read at STAT ↗
1,348 words · retrieved Jun 11
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
National Institutes of Health2Washington University School of Medicine2LEADINGLILLYMonte Rosa Therapeutics, Inc.NOVARTISUNIQUEWM TECHNOLOGY, INC.
drugs
STERILE WATER
topics
Molecular Glue2HematologyOncologyVaccines

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 12h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Aug 26Research into protein interactions sheds new light on causes of autismFierce Biotech
  • Jun 15STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to endSTAT